176 related articles for article (PubMed ID: 29630134)
1. Clinical efficacy of sequential therapy with voriconazole on COPD patients in acute phase with pulmonary aspergillosis and effects on cytokines and pulmonary functions.
Du JF; Chi YM; Song Z; Di QG; Shi J; Lv J; Mai ZT; Li M; Sun BH; Jiang MM
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1837-1842. PubMed ID: 29630134
[TBL] [Abstract][Full Text] [Related]
2. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
Bongomin F; Harris C; Hayes G; Kosmidis C; Denning DW
PLoS One; 2018; 13(4):e0193732. PubMed ID: 29634721
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
Saito T; Fujiuchi S; Tao Y; Sasaki Y; Ogawa K; Suzuki K; Tada A; Kuba M; Kato T; Kawabata M; Kurashima A; Sakatani M;
Infection; 2012 Dec; 40(6):661-7. PubMed ID: 22956473
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series.
Cucchetto G; Cazzadori A; Conti M; Cascio GL; Braggio P; Concia E
Infection; 2015 Jun; 43(3):277-86. PubMed ID: 25432571
[TBL] [Abstract][Full Text] [Related]
5. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract][Full Text] [Related]
7. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Maertens JA; Raad II; Marr KA; Patterson TF; Kontoyiannis DP; Cornely OA; Bow EJ; Rahav G; Neofytos D; Aoun M; Baddley JW; Giladi M; Heinz WJ; Herbrecht R; Hope W; Karthaus M; Lee DG; Lortholary O; Morrison VA; Oren I; Selleslag D; Shoham S; Thompson GR; Lee M; Maher RM; Schmitt-Hoffmann AH; Zeiher B; Ullmann AJ
Lancet; 2016 Feb; 387(10020):760-9. PubMed ID: 26684607
[TBL] [Abstract][Full Text] [Related]
8. Chronic pulmonary aspergillosis: help is on the way.
The Lancet Respiratory Medicine
Lancet Respir Med; 2016 Feb; 4(2):83. PubMed ID: 26868621
[No Abstract] [Full Text] [Related]
9. [Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
Saito W; Shishikura Y; Nishimaki K; Kikuchi T; Sasamori K; Kikuchi Y; Miki H
Kansenshogaku Zasshi; 2014 Jul; 88(4):469-73. PubMed ID: 25199382
[TBL] [Abstract][Full Text] [Related]
10. Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
Bongomin F; Maguire N; Moore CB; Felton T; Rautemaa-Richardson R
Mycoses; 2019 Mar; 62(3):217-222. PubMed ID: 30570179
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety Analysis of Piperacillin Tazobactam in Combination With High Frequency Chest Wall Oscillation in Patients With COPD Coupled With Pneumonia.
Li L; Feng Q; Meng Q; Li F
Altern Ther Health Med; 2023 Jan; 29(1):124-129. PubMed ID: 35986739
[TBL] [Abstract][Full Text] [Related]
12. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
Liu QX; Zheng JP; Xie YQ; Guan WJ; Jiang CY; An JY; Yu XX; Liu WT; Gao Y
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):510-5. PubMed ID: 24262087
[TBL] [Abstract][Full Text] [Related]
13. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
14. Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
Kohno S; Izumikawa K; Ogawa K; Kurashima A; Okimoto N; Amitani R; Kakeya H; Niki Y; Miyazaki Y;
J Infect; 2010 Nov; 61(5):410-8. PubMed ID: 20797407
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
[TBL] [Abstract][Full Text] [Related]
16. Selection of Oral Antifungals for Initial Maintenance Therapy in Chronic Pulmonary Aspergillosis: A Longitudinal Analysis.
Tashiro M; Takazono T; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Kakeya H; Ando T; Ogawa K; Kishi K; Tokimatsu I; Hayashi Y; Fujiuchi S; Yanagihara K; Miyazaki Y; Ichihara K; Mukae H; Kohno S; Izumikawa K
Clin Infect Dis; 2020 Feb; 70(5):835-842. PubMed ID: 30959519
[TBL] [Abstract][Full Text] [Related]
17. Impact of high baseline Aspergillus-specific IgG levels on weight and quality-of-life outcomes of patients with chronic pulmonary aspergillosis.
Bongomin F; Garcez T; Denning DW
Med Mycol; 2020 Oct; 58(7):1000-1004. PubMed ID: 32343313
[TBL] [Abstract][Full Text] [Related]
18. The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
Kosmidis C; Mackenzie A; Harris C; Hashad R; Lynch F; Denning DW
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2233-2237. PubMed ID: 32820348
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Aspergillus Nodule--Still Challenging?
Dabó H; Marinho A; Gomes I
Arch Bronconeumol; 2015 Nov; 51(11):603-4. PubMed ID: 26067097
[No Abstract] [Full Text] [Related]
20. Instillation of Amphotericin B by bronchoscopy combined with systemic voriconazole in advanced non-small cell lung cancer patients with chronic cavitary pulmonary aspergillosis: A case series and literature review.
Wu H; Xiong X; Han Q; Zhuo K; Wang K; Cheng D
J Mycol Med; 2023 Aug; 33(3):101385. PubMed ID: 37031653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
